Bruin, G; Dragatin, C; Aigner, B; Polus, F; Calonder, C; Froeliger, C; Tiffner, K; Bodenlenz, M; Mader, J; Korsatko, S; Ratzer, M; Pieber, TR; Loesche, C; Sinner, F; .
Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).
J INVEST DERMATOL. 2013; 133: S52-S52.-International Investigative Dermatology Meeting; MAY 08-11, 2013; Edinburgh, SCOTLAND.
[Poster]
Web of Science